Urgent Recall: ByHeart Infant Formula Linked to Botulism Outbreak

Understanding the Recall

On November 9, 2025, the Food and Drug Administration (F.D.A.) made a critical announcement regarding ByHeart Whole Nutrition Infant Formula. Health agencies have identified a troubling increase in cases of infant botulism, prompting them to advise parents and caregivers to immediately stop using two specific batches of the product.

The Details Behind the Botulism Cases

As noted by health officials, at least 13 infants across 10 states have been diagnosed with botulism type A since August, directly linked to consumption of the affected formula. The specific batches in question are: 206VABP/251261P2 and 206VABP/251131P2.

“We take any potential safety concern extremely seriously and act quickly to protect families,” said Mia Funt, president of ByHeart.

Parents are advised to be vigilant. If infants exhibit symptoms such as poor feeding, difficulty swallowing, loss of head control, or decreased facial expression, immediate medical consultation is necessary.

The Severity of Botulism

Infant botulism can be fatal if not treated promptly. Symptoms can sometimes take weeks to manifest after consumption of contaminated products. This underlines the critical importance of being aware and proactive.

Impact on Infant Formula Supply

The F.D.A. has estimated that the affected formula batches represent less than 1% of all infant formula sold in the United States. Therefore, this incident should not lead to a nationwide formula shortage. This is a stark contrast to the chaos of 2022, when a nationwide shortage left many parents scrambling for alternatives.

ByHeart's Response

In response to the recall, ByHeart stated that although no botulism spores or toxins have been confirmed in its products, the recall is a preemptive measure to ensure the safety of infants. They have initiated an extensive testing process to rule out any potential risks.

Conclusion

As parents and caregivers, it is imperative to stay informed and act swiftly in situations like this. The F.D.A. continues to monitor the situation closely, in collaboration with the Centers for Disease Control and Prevention (CDC) and other state health agencies. This scenario serves as a reminder of the importance of transparency and safety in the food industry.

Further Information

For more details on this outbreak and how to identify symptoms of botulism, you can visit the F.D.A.'s official disclosure here. Additionally, the CDC provides comprehensive resources regarding infant botulism here.

Key Facts

Recall Announcement Date: November 9, 2025
Affected Products: ByHeart Whole Nutrition Infant Formula
Batch Numbers: 206VABP/251261P2, 206VABP/251131P2
Infant Cases Linked: At least 13 infants diagnosed with botulism type A
States Affected: 10 states
Botulism Severity: Can be fatal if not treated promptly
F.D.A. Supply Impact Estimate: Less than 1% of all infant formula sold
Company Response: Initiated extensive testing process for safety

Background

The recall of specific batches of ByHeart Whole Nutrition Infant Formula was prompted by a rise in infant botulism cases. Health officials have linked 13 cases to the consumption of the affected formula across multiple states.

Quick Answers

When was the ByHeart infant formula recall announced?: The ByHeart infant formula recall was announced on November 9, 2025.
What is the reason for the ByHeart infant formula recall?: The recall is due to a troubling rise in infant botulism cases linked to specific batches of ByHeart Whole Nutrition Infant Formula.
What batch numbers of ByHeart formula are recalled?: The recalled batch numbers are 206VABP/251261P2 and 206VABP/251131P2.
How many infants were diagnosed with botulism linked to ByHeart formula?: At least 13 infants have been diagnosed with botulism type A linked to the affected formula.
What symptoms should parents watch for in infants?: Parents should watch for symptoms such as poor feeding, difficulty swallowing, loss of head control, or decreased facial expression.
Does the recall indicate a nationwide formula shortage?: The F.D.A. states that the affected formula represents less than 1% of all infant formula sold, so it should not lead to a nationwide shortage.
What is ByHeart's response to the recall?: ByHeart stated that the recall is a preemptive measure to ensure safety and has initiated extensive testing to rule out any risks.
What should parents do if an infant shows symptoms of botulism?: Parents should seek immediate medical consultation if infants exhibit symptoms of botulism.

Frequently Asked Questions

What should parents do with the recalled ByHeart formula?

Parents are advised to immediately stop using the recalled ByHeart formula batches.

How is the F.D.A. addressing the botulism situation?

The F.D.A. continues to monitor the situation closely in collaboration with health agencies.

What is infant botulism?

Infant botulism is a serious illness that can be fatal if not treated promptly, caused by toxins from botulinum bacteria.

Source reference: https://www.nytimes.com/2025/11/09/health/infant-formula-botulism-byheart.html